This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Group Limited. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: The Innovations of Seth Paul Finklestein
Introduction
Seth Paul Finklestein is an accomplished inventor based in Durham, NC (US). He has made significant contributions to the field of medical treatment, particularly in the area of stroke therapy. His innovative approach has the potential to improve patient outcomes and advance medical science.
Latest Patents
Finklestein holds a patent for the "Treatment of stroke comprising anti-MAG antibodies." This invention focuses on a dosing regimen for the treatment of stroke, specifically the administration of two doses of anti-MAG antibodies for ischemic and/or hemorrhagic stroke. This patent highlights his commitment to developing effective therapies for critical health issues.
Career Highlights
Finklestein is associated with Glaxo Group Limited, a prominent company in the pharmaceutical industry. His work there has allowed him to collaborate with leading experts and contribute to groundbreaking research in stroke treatment. His dedication to innovation is evident in his patent and ongoing research efforts.
Collaborations
Throughout his career, Finklestein has worked alongside notable colleagues such as Volker Germaschewski and Robert Ian Grundy. These collaborations have fostered a rich environment for innovation and have led to advancements in medical treatments.
Conclusion
Seth Paul Finklestein's contributions to stroke treatment through his patent and work at Glaxo Group Limited exemplify the impact of innovative thinking in medicine. His efforts continue to pave the way for future advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile